Alfred Clinical Trials

Alfred Health has more than 700 open trials across 20 clinical disciplines, our clinical trial portfolio is one of the largest in the country.

Clear filter
604 clinical trials found
Clinical trials

REVISE

Re-EValuating the Inhibition of Stress Erosions and prophylaxis against gastrointestinal bleeding in the critically ill (REVISE) trial (NCT03374800)

Recently completed/closed

RESPONDER-HF

Re-Evaluation of the Corvia Atrial Shunt Device in a Precision Medicine Trial to Determine Efficacy in Mildly Reduced or Preserved EF Heart Failure (RESPONDER-HF) (NCT05425459)

Currently recruiting

ReCAPS

Recovery-focused Community support to Avoid readmissions and improve participation after Stroke (ACTRN12618001468213)

Currently recruiting

ROSETTA

Red Blood Cell Transfusion in ECMO - a feasibility trial (NCT05814094)

No longer recruiting

REDEEM

REDEEM: A randomised controlled trial of VV ECMO to de-sedate, extubate, and mobilise in hypoxic respiratory failure. (NCT05562505)

Currently recruiting

REFORM

Reducing the frequency of outpatient review in people with cystic fibrosis on high-efficacy modulator therapy – a non-inferiority, randomised controlled trial (REFORM) (ACTRN12624000696594)

Currently recruiting

ROCKET

Reduction Of Chronic Post-surgical Pain with Ketamine - ROCKet Trial (ACTRN12617001619336)

No longer recruiting

RESPOCT-ED Study

RESpiratory pathogen Point-Of-Care Testing in Emergency Departments (ACTRN12625000123448)

Currently recruiting

AMaRC 21-04

Risk Directed front-line therapy for Multiple Myeloma incorporating Selinexor: The RIDDLE-M-X trial (ACTRN12622001366741)

Currently recruiting

EXPANDS-1

Safety and Effectiveness of an Expandable/Retractable Introducer Sheath (ACTRN12623000479606p)

Currently recruiting

NIVO-LD

Safety, immunogenicity and efficacy of low dose Nivolumab in adults living with HIV on antiretroviral therapy (ART): NIVO-LD (NCT05187429)

Currently recruiting

STARWARS

Salvage sTereotactic Ablative radiotherapy for Recurrent prostate cancer With Androgen suppression and Rectal Spacer (ACTRN12625000224426)

Currently recruiting

SEARCH

Screening for Early onset Amyloid Related Cerebral Hemorrhage

Currently recruiting

SAFER-TAVI

Secondary Access - FEmoral or radial in Transcatheter Aortic Valve Implantation TAVI? (NCT06284837)

Currently recruiting

COMB157GAU01

Secondary use of data study characterizing Kesimpta (ofatumumab) onboarding and utilization in RMS patients using MSGo, with a non-interventional primary use of data sub-study comparing Patient Reported Outcomes relative to Clinical Outcomes (EAFToS) (NCT05090033)

No longer recruiting

SAD-AF

Selective Serotonin Reuptake Inhibitors And Depression in Atrial Fibrillation (SAD-AF) (ACTRN12623000227695p)

Currently recruiting

SMITE

SMITE: Superiority of Migraine Inpatient Treatment with Eptinezumab (ACTRN12621001616864)

Currently recruiting

SODa-BIC

SODa-BIC: Sodium Bicarbonate For Metabolic Acidosis in the Intensive Care Unit, A Multicentre, Randomised, Double-Blind Clinical Trial (NCT05697770)

Currently recruiting

SODa-BIC

SODium BICarbonate for metabolic acidosis in the Intensive Care Unit: A pilot, multicentre,randomized, double-blindclinical trial. (ACTRN12620001361998)

Recently completed/closed

SUPER-ED

Solving Unknown Primary cancER Earlier Diagnosis [SUPER-ED]: A stepped wedge cluster randomised controlled trial implementing a Model of Care to support earlier diagnosis (ACTRN12622001504707)

Currently recruiting
26 27 28 29 30